Austin Wesevich, Megan Elizabeth Woelkers, Ayodeji Adegunsoye, Adam J Wesevich, Mark J Ratain, Gabrielle Lapping-Carr
{"title":"Triaging Acute Chest Syndrome Clinical Decision-Making Using Bedside SaO2/FiO2 Ratio.","authors":"Austin Wesevich, Megan Elizabeth Woelkers, Ayodeji Adegunsoye, Adam J Wesevich, Mark J Ratain, Gabrielle Lapping-Carr","doi":"10.1182/bloodadvances.2024015139","DOIUrl":null,"url":null,"abstract":"<p><p>Acute chest syndrome (ACS) severity is inconsistently defined and its clinical course difficult to predict. This retrospective observational study evaluated the utility of the ratio of the pulse oximetry oxygen saturation to the fraction of inspired oxygen (SaO2/FiO2) in adult patients with ACS and its association with the clinical outcome of intensive care unit (ICU) transfer. Across all ACS hospitalizations at a tertiary medical center from 2017-2021, we characterized the SaO2/FiO2 ratio at 3 timepoints: emergency department (ED) presentation, diagnosis with ACS, and antibiotic initiation. Of the 227 hospitalizations identified, 54% were female, mean age was 29, 70% had Hgb SS, and 9% had obesity. While ICU transfer was not strongly associated with the SaO2/FiO2 ratio at ED presentation (AUC 0.59), it was strongly associated with the SaO2/FiO2 ratio at ACS diagnosis (AUC 0.73) and antibiotic initiation (AUC 0.74). Given the highest sensitivity at ACS diagnosis, a diagnostic SaO2/FiO2 cutoff of 310 was proposed for triaging likely ICU transfer (sensitivity 63%, specificity 82%, aOR 8.94, 95% CI 2.12-37.6, adjusted HR 4.86, 95% CI 1.91-12.4) with models adjusting for obesity, lung disease, and blood counts. This cutoff corresponds to an SpO2 below 90% on 2 L/min nasal cannula support. We propose using the SaO2/FiO2 ratio cutoff of 310 prospectively as a simple bedside triage tool for adult patients with sickle cell disease hospitalized with ACS to be transferred to a higher level of care.</p>","PeriodicalId":9228,"journal":{"name":"Blood advances","volume":" ","pages":""},"PeriodicalIF":7.4000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood advances","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/bloodadvances.2024015139","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Triaging Acute Chest Syndrome Clinical Decision-Making Using Bedside SaO2/FiO2 Ratio.
Acute chest syndrome (ACS) severity is inconsistently defined and its clinical course difficult to predict. This retrospective observational study evaluated the utility of the ratio of the pulse oximetry oxygen saturation to the fraction of inspired oxygen (SaO2/FiO2) in adult patients with ACS and its association with the clinical outcome of intensive care unit (ICU) transfer. Across all ACS hospitalizations at a tertiary medical center from 2017-2021, we characterized the SaO2/FiO2 ratio at 3 timepoints: emergency department (ED) presentation, diagnosis with ACS, and antibiotic initiation. Of the 227 hospitalizations identified, 54% were female, mean age was 29, 70% had Hgb SS, and 9% had obesity. While ICU transfer was not strongly associated with the SaO2/FiO2 ratio at ED presentation (AUC 0.59), it was strongly associated with the SaO2/FiO2 ratio at ACS diagnosis (AUC 0.73) and antibiotic initiation (AUC 0.74). Given the highest sensitivity at ACS diagnosis, a diagnostic SaO2/FiO2 cutoff of 310 was proposed for triaging likely ICU transfer (sensitivity 63%, specificity 82%, aOR 8.94, 95% CI 2.12-37.6, adjusted HR 4.86, 95% CI 1.91-12.4) with models adjusting for obesity, lung disease, and blood counts. This cutoff corresponds to an SpO2 below 90% on 2 L/min nasal cannula support. We propose using the SaO2/FiO2 ratio cutoff of 310 prospectively as a simple bedside triage tool for adult patients with sickle cell disease hospitalized with ACS to be transferred to a higher level of care.
期刊介绍:
Blood Advances, a semimonthly medical journal published by the American Society of Hematology, marks the first addition to the Blood family in 70 years. This peer-reviewed, online-only, open-access journal was launched under the leadership of founding editor-in-chief Robert Negrin, MD, from Stanford University Medical Center in Stanford, CA, with its inaugural issue released on November 29, 2016.
Blood Advances serves as an international platform for original articles detailing basic laboratory, translational, and clinical investigations in hematology. The journal comprehensively covers all aspects of hematology, including disorders of leukocytes (both benign and malignant), erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. Each article undergoes a rigorous peer-review process, with selection based on the originality of the findings, the high quality of the work presented, and the clarity of the presentation.